Naltrexone Completed Phase 1 / 2 Trials for Human Immunodeficiency Virus (HIV) Infections / Alcohol Use / Pain NOS Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01780233Pharmacokinetic Study of Fentanyl 400 µg Sublingual Spray, Actiq® 400 µg Transmucosally, and Fentanyl Citrate Injection 100 µg Intravenously (iv)